Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Here’s Why Supernus Pharmaceuticals, Rent-A-Center and Three Other Stocks are Down Today

Page 1 of 2

Stocks are extending losses on Tuesday, mainly due to healthcare sector, which is down over 2%, and slipping crude prices. The Dow Jones industrial average fell around 170 points, while S&P 500 and NASDAQ down over 1% each.  Among the big losers today include Supernus Pharmaceuticals Inc (NASDAQ:SUPN), Rent-A-Center Inc (NASDAQ:RCII), Msci Inc (NYSE:MSCI), Integrated Device Technology Inc (NASDAQ:IDTI), and IntelliPharmaCeutics Intl Inc (USA) (NASDAQ:IPCI). In this article, we will find out why these stocks have tumbled and also analyze the hedge fund sentiment towards them to get a clearer picture.  

We believe that imitating hedge funds and other large institutional investors can be helpful in identifying stocks capable of outperforming the broader market. Through extensive research that covered portfolios of several hundred large investors between 1999 and 2012, we determined that following the small-cap stocks that large money managers are collectively bullish on, can generate monthly returns nearly 1.0 percentage points above the market (see more details here).

computers, work,

Tonis Valing / Shutterstock.com

Supernus Pharmaceuticals Posts Results of ADHD Drug Trial

Supernus Pharmaceuticals Inc (NASDAQ:SUPN)’s stock gained over 5% this morning before going deep in the red after the company announced positive top-line results from its Phase IIb dose-ranging clinical trial of SPN-812 in children for the treatment of attention deficit hyperactivity disorder (ADHD). The trial successfully met its primary endpoint, and achieved “statistically significant” improvement in the symptoms of ADHD, according to a statement released by the Maryland-based pharmaceutical company. However, patients receiving SPN 100 mg had a -16.7 point change from baseline in the primary endpoint and a median effect size of 0.46, which falls short of statistical significance. The company said only two patients experienced three adverse events of severe category, and there were no deaths in the study. A total of 18 funds from our database were long Supernus Pharmaceuticals Inc (NASDAQ:SUPN) at the end of June, down from 24 funds a quarter earlier.

Follow Supernus Pharmaceuticals Inc (NASDAQ:SUPN)
Trade (NASDAQ:SUPN) Now!
 

Rent-A-Center Posts Dismal Q3 Estimates

Rent-A-Center Inc (NASDAQ:RCII)’s stock has lost over 29% after the company said it expects third-quarter earnings per share between $0.5 and $0.15, well below the consensus estimate of $0.39. Same-store sales in the US are expected to come in at 12%, while same-store sales for Acceptance Now brand stores are expected to be flat on the year. Rent-A-Center Inc (NASDAQ:RCII)’s CEO Robert Davis said in a statement that the company faced “performance issues” and outages after making a transition to a new point-of-sale system and added that it would take “several quarters” to recover from the effects of the transition. However, Davis is hopeful about the improvement in system performance. At the end of the second quarter, 19 funds tracked by Insider Monkey held stakes in Rent-A-Center Inc (NASDAQ:RCII).

Follow Rent A Center Inc De (NASDAQ:RCII)
Trade (NASDAQ:RCII) Now!

Move on to the next page to read why Msci, Integrated Device Technology and IntelliPharmaCeutics are losing value today. 

Page 1 of 2
Loading Comments...